5 studies were found.

1.		Recruiting	Open label study of ONTAK (denileukin diftitox) in previously treated Cutaneous T-cell Lymphoma patients. Conditions: Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome
2.		Recruiting	Phase II randomized bilateral comparison of topical targretin gel 1% in alopecia areata Condition: Alopecia Areata
3.		Recruiting	Phase II study of ONTAK in previously treated patients with low-grade Non-Hodgkin's Lymphoma (NHL) Conditions: Non-Hodgkin's Lymphoma; Lymphoma, B-Cell; Lymphoma, Low-Grade
4.		Recruiting	Randomized double-blind study of ONTAK (denileukin diftitox) in cutaneous T-cell lymphoma (CTCL) patients. Conditions: Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome
5.		Recruiting	Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Condition: Leukemia, Lymphocytic, Chronic